BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rihawi K, Ricci AD, Rizzo A, Brocchi S, Marasco G, Pastore LV, Llimpe FLR, Golfieri R, Renzulli M. Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications. Int J Mol Sci 2021;22:3805. [PMID: 33916915 DOI: 10.3390/ijms22083805] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Wang S, Ma X, Wang T, Lu R, Jia X, Leng Z, Kong X, Zhang J, Li L. Ranitidine as an adjuvant regulates macrophage polarization and activates CTLs through the PI3K-Akt2 signaling pathway. International Immunopharmacology 2023;116:109729. [DOI: 10.1016/j.intimp.2023.109729] [Reference Citation Analysis]
2 Hang S, Wang N, Sugimura R. T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells. Differentiation 2023;130:51-7. [PMID: 36682340 DOI: 10.1016/j.diff.2023.01.001] [Reference Citation Analysis]
3 Liu K, Lu H, Jiang D, Guan Y, Xu H, Sun Q, Jiang Q, Zheng J, Chen H, Zhang F, Luo R, Huang Y, Xu J, Hou Y. Prognostic Significance of CDK6 Amplification in Esophageal Squamous Cell Carcinoma. Cancer Treatment and Research Communications 2023. [DOI: 10.1016/j.ctarc.2023.100698] [Reference Citation Analysis]
4 Jang YS, Kim TW, Ryu JS, Kong HJ, Jang SH, Nam GH, Kim JH, Jeon S. Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells. PLoS One 2023;18:e0277285. [PMID: 36757936 DOI: 10.1371/journal.pone.0277285] [Reference Citation Analysis]
5 Liu W, Zhu M, Li X, Er L, Li S. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer. Dis Markers 2023;2023:9226712. [PMID: 36817086 DOI: 10.1155/2023/9226712] [Reference Citation Analysis]
6 Yuan JQ, Wang SM, Guo L. S100A9 promotes glycolytic activity in HER2-positive breast cancer to induce immunosuppression in the tumour microenvironment. Heliyon 2023;9:e13294. [PMID: 36755606 DOI: 10.1016/j.heliyon.2023.e13294] [Reference Citation Analysis]
7 Yan H, Zhang JL, Leung KT, Lo KW, Yu J, To KF, Kang W. An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis. Cancers (Basel) 2023;15. [PMID: 36765694 DOI: 10.3390/cancers15030736] [Reference Citation Analysis]
8 Jakubik J, Majos A, Jesionek-Kupnicka D, Wrona E, Kaufman-Szymczyk A, Lubecka-Gajewska K, Jakubik J. An unusual non‑metastatic, mismatch repair‑deficient primary gastric squamous cell carcinoma presenting as a large, exophytic, bleeding tumor: A case report. Oncol Lett 2023;25:82. [PMID: 36760516 DOI: 10.3892/ol.2023.13668] [Reference Citation Analysis]
9 Hong X, Zhuang K, Xu N, Wang J, Liu Y, Tang S, Zhao J, Huang Z. An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma. Front Mol Biosci 2022;9:1022056. [PMID: 36660425 DOI: 10.3389/fmolb.2022.1022056] [Reference Citation Analysis]
10 Zhao W, Lin J, Cheng S, Li H, Shu Y, Xu C. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer. PeerJ 2023;11:e14645. [PMID: 36919165 DOI: 10.7717/peerj.14645] [Reference Citation Analysis]
11 Shin GY, Park JY, Lee SH, Cho YK, Choi MG, Park JM. Tumor heterogeneity and carcinoma in resected specimens of gastric low-grade dysplasia: A retrospective single center study. PLoS One 2023;18:e0280735. [PMID: 36696374 DOI: 10.1371/journal.pone.0280735] [Reference Citation Analysis]
12 Aleebrahim-dehkordi E, Deravi N, Fallahi MS, Rezaei N. Mechanisms Underlying Tumor-Associated Macrophages (TAMs)-Facilitated Metastasis. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_66-1] [Reference Citation Analysis]
13 Schizas D, Mylonas KS, Syllaios A, Kapetanakis EI, Hasemaki N, Ntomi V, Michalinos A, Theochari NA, Theochari CA, Krivan S, Mpoura M, Bakopoulos A, Karavokyros I, Liakakos T. Gastrectomy for Cancer: A 15-Year Analysis of Real-World Data from the University of Athens. Medicina (Kaunas) 2022;58. [PMID: 36556994 DOI: 10.3390/medicina58121792] [Reference Citation Analysis]
14 Vaes N, Idris M, Boesmans W, Alves MM, Melotte V. Nerves in gastrointestinal cancer: from mechanism to modulations. Nat Rev Gastroenterol Hepatol 2022;19:768-84. [PMID: 36056202 DOI: 10.1038/s41575-022-00669-9] [Reference Citation Analysis]
15 Han Q, Zhang X, Zhang J, Zhou W, Chen Q, Chen Y, Yan W, Lin A. Pre-operative neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with gastric cancer. International Immunopharmacology 2022;113:109371. [DOI: 10.1016/j.intimp.2022.109371] [Reference Citation Analysis]
16 Ruiz JI, Singh G, Erck M, Geng Y, Suarez-Almazor ME, Lopez-Olivo MA. Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan. PLoS One 2022;17:e0275676. [PMID: 36215234 DOI: 10.1371/journal.pone.0275676] [Reference Citation Analysis]
17 Lee WY, Yoon BW. An Extremely Rare Case of Thyroid Metastasis from Advanced Gastric Cancer. Case Rep Oncol 2022;15:841-7. [PMID: 36825094 DOI: 10.1159/000526572] [Reference Citation Analysis]
18 Liu X, Zhao J, Li X, Lao F, Fang M. Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy. Vaccines (Basel) 2022;10:1552. [PMID: 36146629 DOI: 10.3390/vaccines10091552] [Reference Citation Analysis]
19 Yu H, Xu L, Yin S, Jiang J, Hong C, He Y, Zhang C. Risk Factors and Prognostic Impact of Postoperative Complications in Patients with Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy. Current Oncology 2022;29:6496-6507. [DOI: 10.3390/curroncol29090511] [Reference Citation Analysis]
20 Agnarelli A, Vella V, Samuels M, Papanastasopoulos P, Giamas G. Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. Cancers 2022;14:4378. [DOI: 10.3390/cancers14184378] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhang X, Li Y, Hu P, Xu L, Qiu H. Identification of molecular patterns and prognostic models of epithelial–mesenchymal transition- and immune-combined index in the gastric cancer. Front Pharmacol 2022;13:958070. [DOI: 10.3389/fphar.2022.958070] [Reference Citation Analysis]
22 Li M, Zheng Y, Zhao J, Liu M, Shu X, Li Q, Wang Y, Zhou Y. Polyphenol Mechanisms against Gastric Cancer and Their Interactions with Gut Microbiota: A Review. Current Oncology 2022;29:5247-5261. [DOI: 10.3390/curroncol29080417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Dong Z, Zhang Y, Geng H, Ni B, Xia X, Zhu C, Liu J, Zhang Z. Development and validation of two nomograms for predicting overall survival and cancer-specific survival in gastric cancer patients with liver metastases: A retrospective cohort study from SEER database. Transl Oncol 2022;24:101480. [PMID: 35868142 DOI: 10.1016/j.tranon.2022.101480] [Reference Citation Analysis]
24 Sun C, Chen Y, Kim NH, Lowe S, Ma S, Zhou Z, Bentley R, Chen Y, Tuason MW, Gu W, Bhan C, Tuason JPW, Thapa P, Cheng C, Zhou Q, Zhu Y. Identification and Verification of Potential Biomarkers in Gastric Cancer By Integrated Bioinformatic Analysis. Front Genet 2022;13:911740. [DOI: 10.3389/fgene.2022.911740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang C, Yamashita H, Okumura Y, Yagi K, Aikou S, Seto Y. Signature and Prediction of Perigastric Lymph Node Metastasis in Patients with Gastric Cancer and Total Gastrectomy: Is Total Gastrectomy Always Necessary? Cancers 2022;14:3409. [DOI: 10.3390/cancers14143409] [Reference Citation Analysis]
26 Wang G, Yang L, Wang Y, Hu R, Zhang K, Guo T, Chen B, Jiang X, Cui R. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer. Front Immunol 2022;13:939836. [DOI: 10.3389/fimmu.2022.939836] [Reference Citation Analysis]
27 Hernandez J, Turner MA, Bali P, Hosseini M, Bouvet M, Kelly K, Obonyo M. Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5. Current Oncology 2022;29:4725-4734. [DOI: 10.3390/curroncol29070375] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Sung J, Cheong J. Machine Learning Predictor of Immune Checkpoint Blockade Response in Gastric Cancer. Cancers 2022;14:3191. [DOI: 10.3390/cancers14133191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Spirina LV, Avgustinovich AV, Bakina OV, Afanas'ev SG, Volkov MY, Kebekbayeva AY. LC3B, mTOR, AMPK Are Molecular Targets for Neoadjuvant Chemotherapy in Gastric Cancers. Curr Issues Mol Biol 2022;44:2772-82. [PMID: 35877414 DOI: 10.3390/cimb44070190] [Reference Citation Analysis]
30 Yu P, Liang P, Pang S, Yuan W, Zhao Y, Huang Q. The Function, Role and Process of DDX58 in Heart Failure and Human Cancers. Front Oncol 2022;12:911309. [DOI: 10.3389/fonc.2022.911309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yeh JH, Yeh YS, Tsai HL, Huang CW, Chang TK, Su WC, Wang JY. Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at? Cancers (Basel) 2022;14:3026. [PMID: 35740693 DOI: 10.3390/cancers14123026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Kalfon T, Loewenstein S, Gerstenhaber F, Leibou S, Geller H, Sher O, Nizri E, Lahat G. Gastric Cancer-Derived Extracellular Vesicles (EVs) Promote Angiogenesis via Angiopoietin-2. Cancers (Basel) 2022;14:2953. [PMID: 35740619 DOI: 10.3390/cancers14122953] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Xu B, Chen F, Zhang X, Wang Z, Che K, Wu N, Yu L, Fan X, Liu B, Wei J. Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer. Cancers 2022;14:2758. [DOI: 10.3390/cancers14112758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ucaryilmaz Metin C, Ozcan G. The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer. Cancers (Basel) 2022;14:2711. [PMID: 35681691 DOI: 10.3390/cancers14112711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Konopka K, Frączek P, Lubaś M, Micek A, Kwinta Ł, Streb J, Potocki P, Wysocki PJ. Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer. J Clin Med 2022;11:1213. [PMID: 35268305 DOI: 10.3390/jcm11051213] [Reference Citation Analysis]
36 Albracht SP. Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto. Cancer Treatment and Research Communications 2022. [DOI: 10.1016/j.ctarc.2022.100537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Yang Y, Meng WJ, Wang ZQ. Cancer Stem Cells and the Tumor Microenvironment in Gastric Cancer. Front Oncol 2021;11:803974. [PMID: 35047411 DOI: 10.3389/fonc.2021.803974] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
38 Qin Y, Li M, Lin Q, Pan X, Liang Y, Huang Z, Liu Z, Huang L, Fang M. Colorectal Cancer Cell Differentiation Trajectory Predicts Patient Immunotherapy Response and Prognosis. Cancer Control 2022;29:10732748221121382. [PMID: 36036380 DOI: 10.1177/10732748221121382] [Reference Citation Analysis]
39 Chabeli MS, Wang X, Yinghao L, Chen C, Yang C, Shou Y, Wang S, Chen K. Similarities between wound re-epithelialization and Metastasis in ESCC and the crucial involvement of macrophages: A review. Cancer Treatment and Research Communications 2022;32:100621. [DOI: 10.1016/j.ctarc.2022.100621] [Reference Citation Analysis]
40 Wang W, Shen H, Liu Z, Chen Y, Hou L, Ding Y. Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression. Cancer Treatment and Research Communications 2022;32:100592. [DOI: 10.1016/j.ctarc.2022.100592] [Reference Citation Analysis]
41 Liu Z, Liang Y, Tang X, Qu H. Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer. Front Surg 2021;8:745748. [PMID: 34869556 DOI: 10.3389/fsurg.2021.745748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ieni A, Caruso RA, Pizzimenti C, Giuffrè G, Irato E, Rigoli L, Navarra G, Fadda G, Tuccari G. M1 Polarized Tumor-Associated Macrophages (TAMs) as Promising Prognostic Signature in Stage I–II Gastric Adenocarcinomas. GastrointestDisord 2021;3:207-17. [DOI: 10.3390/gidisord3040020] [Reference Citation Analysis]
43 Yang Y, Yang Y, Chen M, Chen J, Wang J, Ma Y, Qian H. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages. Biomater Sci 2021;9:6597-608. [PMID: 34582523 DOI: 10.1039/d1bm01053k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
44 Liu X, Yao L, Qu J, Liu L, Lu N, Wang J, Zhang J. Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression. J Transl Med 2021;19:325. [PMID: 34332586 DOI: 10.1186/s12967-021-03012-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]